SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-15-385721
Filing Date
2015-11-24
Accepted
2015-11-23 21:38:05
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-1 d49718ds1.htm S-1 1674846
2 EX-10.8 d49718dex108.htm EX-10.8 4320
3 EX-10.16 d49718dex1016.htm EX-10.16 17122
4 EX-23.1 d49718dex231.htm EX-23.1 1596
5 GRAPHIC g49718g14s86.jpg GRAPHIC 47524
6 GRAPHIC g49718g27i73.jpg GRAPHIC 80563
7 GRAPHIC g49718g42z96.jpg GRAPHIC 78182
8 GRAPHIC g49718g62o98.jpg GRAPHIC 64013
9 GRAPHIC g49718g65z73.jpg GRAPHIC 63802
10 GRAPHIC g49718g66y98.jpg GRAPHIC 48662
11 GRAPHIC g49718g68m32.jpg GRAPHIC 15066
  Complete submission text file 0001193125-15-385721.txt   2247212
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-208182 | Film No.: 151251020
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences